These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8363226

  • 1. Guanine arabinoside as a bone marrow-purging agent.
    Kurtzberg J.
    Ann N Y Acad Sci; 1993 Jun 23; 685():225-36. PubMed ID: 8363226
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC, Chaffee S, Hebert ME, Halperin EC, Friedman HS, Kurtzberg J.
    Leukemia; 1993 Aug 23; 7(8):1261-7. PubMed ID: 8350627
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanine.
    Hebert ME, Greenberg ML, Chaffee S, Gravatt L, Hershfield MS, Elion GB, Kurtzberg J.
    Transplantation; 1991 Oct 23; 52(4):634-40. PubMed ID: 1926342
    [Abstract] [Full Text] [Related]

  • 4. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS, Mitchell BS.
    Cancer Res; 1989 Dec 01; 49(23):6498-502. PubMed ID: 2819707
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.
    Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA.
    Bone Marrow Transplant; 2000 Mar 01; 25(6):639-45. PubMed ID: 10734298
    [Abstract] [Full Text] [Related]

  • 6. Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints.
    Leanza L, Miazzi C, Ferraro P, Reichard P, Bianchi V.
    Exp Cell Res; 2010 Dec 10; 316(20):3443-53. PubMed ID: 20603113
    [Abstract] [Full Text] [Related]

  • 7. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R, Grünebach F, Bader P, Vogel W, Kanz L, Brugger W, Scheding S.
    J Hematother Stem Cell Res; 2001 Dec 10; 10(6):777-85. PubMed ID: 11798504
    [Abstract] [Full Text] [Related]

  • 8. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
    Dietzfelbinger HF, Lang A, Oberberg D, Rastetter JW, Berdel WE.
    Exp Hematol; 1992 Feb 10; 20(2):178-83. PubMed ID: 1544386
    [Abstract] [Full Text] [Related]

  • 9. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS, Sikic BI, Blume KG, Chao NJ.
    Exp Hematol; 1992 Oct 10; 20(9):1048-54. PubMed ID: 1468539
    [Abstract] [Full Text] [Related]

  • 10. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Oct 10; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 11. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L, Hu C, Giarratana MC, Bouchet S, Conlon J, Capizzi RL, Gorin NC.
    Blood; 1995 Oct 01; 86(7):2849-55. PubMed ID: 7670119
    [Abstract] [Full Text] [Related]

  • 12. Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations.
    Lau C, Wang E, Ishaque A, Jones K, Wong B, Kimsto L, Conant J.
    Int J Immunopharmacol; 1992 Aug 01; 14(6):1081-91. PubMed ID: 1428363
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
    Vogler WR, Berdel WE, Olson AC, Winton EF, Heffner LT, Gordon DS.
    Blood; 1992 Sep 15; 80(6):1423-9. PubMed ID: 1520869
    [Abstract] [Full Text] [Related]

  • 14. Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells.
    Curbo S, Zhu C, Johansson M, Balzarini J, Karlsson A.
    Biochem Biophys Res Commun; 2001 Jul 06; 285(1):40-5. PubMed ID: 11437369
    [Abstract] [Full Text] [Related]

  • 15. Clinically relevant deoxycytidine levels are high enough to profoundly alter 9-beta-D-arabinofuranosylguanine cytotoxicity for human T-cell acute leukemia cells in vitro.
    Cohen JD, Strock DJ, Teik JE, LaGuardia EA, Katz TB.
    Pediatr Hematol Oncol; 1999 Jul 06; 16(3):239-44. PubMed ID: 10326222
    [Abstract] [Full Text] [Related]

  • 16. Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets.
    Cesano A, Pierson G, Visonneau S, Migliaccio AR, Santoli D.
    Blood; 1996 Jan 01; 87(1):393-403. PubMed ID: 8547668
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic marrow purging in murine T cell leukemia.
    Copelan EA, Johnson SC, Grever MR, Sheridan JF, Tutschka PJ.
    Blood; 1988 Jun 01; 71(6):1656-61. PubMed ID: 2836002
    [Abstract] [Full Text] [Related]

  • 18. Nelarabine: a new purine analog in the treatment of hematologic malignancies.
    Curbo S, Karlsson A.
    Rev Recent Clin Trials; 2006 Sep 01; 1(3):185-92. PubMed ID: 18473971
    [Abstract] [Full Text] [Related]

  • 19. Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
    Scheffold C, Schöttker B, Lefterova P, Csipai M, Glasmacher A, Huhn D, Neubauer A, Schmidt-Wolf IG.
    Acta Haematol; 2000 Sep 01; 104(2-3):72-9. PubMed ID: 11154978
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM.
    Blood; 1989 Jul 01; 74(1):501-6. PubMed ID: 2665843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.